106 related articles for article (PubMed ID: 2676761)
1. [The peripheral hormone level in premenopausal patients with benign breast changes and their modification by various hormone therapies].
Bohnet HG; Bertram M
Gynakologe; 1989 Aug; 22(4):255-61. PubMed ID: 2676761
[No Abstract] [Full Text] [Related]
2. [Danazol therapy in benign breast diseases].
Goebel R; Junkermann H; von Fournier D
Gynakologe; 1989 Aug; 22(4):262-70. PubMed ID: 2676762
[No Abstract] [Full Text] [Related]
3. [Mechanism of action of danazol, personal clinical experiences and guidelines for the treatment of benign breast diseases].
Schindler AE; Schindler EM
Gynakologe; 1989 Aug; 22(4):271-3. PubMed ID: 2676763
[No Abstract] [Full Text] [Related]
4. [The significance of gestagens in treatment of mastopathy].
Schweppe KW
Zentralbl Gynakol; 1997; 119 Suppl 2():54-8. PubMed ID: 9441542
[TBL] [Abstract][Full Text] [Related]
5. Benign breast diseases: risk factor or precancerous state?
Gerber M
Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():113-8. PubMed ID: 8298440
[No Abstract] [Full Text] [Related]
6. [Some aspects of fibrocystic breast disease].
Mizia-Stec K; Zych F
Pol Merkur Lekarski; 1997 May; 2(11):303-6. PubMed ID: 9377675
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of benign breast pathology with bromocriptine].
Tolino A; Cardone A; Mastrantonio P; Chiacchio G
Riv Ital Ginecol; 1977; 58(5):371-8. PubMed ID: 555037
[No Abstract] [Full Text] [Related]
8. Tamoxifen responders selection by computerized contact thermography in benign breast disease.
Cupceancu B; Mogoş I; Cotruţă C
Endocrinologie; 1986; 24(2):115-22. PubMed ID: 3738400
[TBL] [Abstract][Full Text] [Related]
9. [Is fibrocystic disease precancerous?].
De León Antoni E
Bol Asoc Med P R; 1989 Nov; 81(11):451-4. PubMed ID: 2690835
[TBL] [Abstract][Full Text] [Related]
10. Use of risk factors in counseling patients.
Love SM
Hematol Oncol Clin North Am; 1989 Dec; 3(4):599-610. PubMed ID: 2691491
[TBL] [Abstract][Full Text] [Related]
11. [Thermography in the diagnosis of benign breast diseases].
Lauth G; Duda V; Thein T
Gynakologe; 1989 Aug; 22(4):242-5. PubMed ID: 2792912
[No Abstract] [Full Text] [Related]
12. Plasma isoflavones and fibrocystic breast conditions and breast cancer among women in Shanghai, China.
Lampe JW; Nishino Y; Ray RM; Wu C; Li W; Lin MG; Gao DL; Hu Y; Shannon J; Stalsberg H; Porter PL; Frankenfeld CL; Wähälä K; Thomas DB
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2579-86. PubMed ID: 18086761
[TBL] [Abstract][Full Text] [Related]
13. Benign breast disease.
Mauvais-Jarvis P; Kuttenn F
Curr Ther Endocrinol Metab; 1994; 5():364-70. PubMed ID: 7704754
[No Abstract] [Full Text] [Related]
14. Beyond fibrocystic disease. The evolving concept of pre-malignant breast disease.
Shirley SE
West Indian Med J; 1999 Dec; 48(4):173-8. PubMed ID: 10639833
[TBL] [Abstract][Full Text] [Related]
15. Biochemistry of breast cyst fluid: correlation with breast cancer risk.
Ann N Y Acad Sci; 1990; 586():1-294. PubMed ID: 2356992
[No Abstract] [Full Text] [Related]
16. Is 'fibrocystic disease' of the breast precancerous? A consensus report from the College of American Pathologists.
Indiana Med; 1986 Sep; 79(9):753-4. PubMed ID: 3772069
[No Abstract] [Full Text] [Related]
17. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types.
Marshall LM; Hunter DJ; Connolly JL; Schnitt SJ; Byrne C; London SJ; Colditz GA
Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):297-301. PubMed ID: 9149887
[TBL] [Abstract][Full Text] [Related]
18. Cytomorphology of fibrocystic change, high-risk proliferative breast disease, and premalignant breast lesions.
Masood S
Clin Lab Med; 2005 Dec; 25(4):713-31, vi. PubMed ID: 16308088
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for fibrocystic breast disease and its histopathologic components.
Berkowitz GS; Kelsey JL; LiVolsi VA; Holford TR; Merino MJ; Ort S; O'Connor TZ; White C
J Natl Cancer Inst; 1985 Jul; 75(1):43-50. PubMed ID: 3859695
[TBL] [Abstract][Full Text] [Related]
20. Effect of a low-fat diet on hormone levels in women with cystic breast disease. II. Serum radioimmunoassayable prolactin and growth hormone and bioactive lactogenic hormones.
Rose DP; Cohen LA; Berke B; Boyar AP
J Natl Cancer Inst; 1987 Apr; 78(4):627-31. PubMed ID: 3470539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
